GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75F40120F19005BIOPHARMA SERVICES USA

Overview

Award facts

Net obligations
$1.85M
$1,845,195of $1.85M potential value
Outlays (paid to date)
$117.04K
$117.04K paid of $1.85M obligated$117,041
Period of performance
Mar 10, 2020 to May 31, 2022
Ended
Modifications
5
Latest action Jun 21, 2024
Contract type
Delivery order
PIID 75F40120F19005

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

NEW TASK ORDER UNDER IDIQ CONTRACT HHSF223201610004I ENTITLED, "A RANDOMIZED, OPEN LABEL, TWO TREATMENT, FOUR PERIOD, SINGLE DOSE, FULLY REPLICATE, CROSSOVER BIOEQUIVALENCE (BE) STUDY OF TACROLIMUS CAPSULES 5 MG"

Dates and value

Award date
Signed on Mar 10, 2020
Potential end of performance
May 30, 2022
Current value
$1,845,195Base and exercised options
Potential value (if all options are exercised)
$1,845,195
Parent contract vehicle
HHSF223201610004I (IDC, single award) — 4 orders recorded under it

Obligations by fiscal year of action

  • FY2024: -$1 (de-obligation)
  • FY2022: $19,744
  • FY2020: $1,825,452

Total across 3 fiscal years: $1,845,195

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 21, 2024. View on USAspending · Recipient on SAM.gov

Recipient

NameBIOPHARMA SERVICES USA
LocationCOLUMBIA, MO
UEIDRLXCANKKNN6
CAGE code7G0A9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBIOPHARMA SERVICES USA

Business types and certifications

Foreign-ownedFor-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Columbia, Boone County, Missouri 65201-6569
Congressional district (place of performance)
MO-04As reported at the time of the action

Classification and competition

Classification

NAICS
541690OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
Product or service (PSC)
B528SPECIAL STUDIES/ANALYSIS- REGULATORY (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Firm fixed priceJ

Contract details

Subcontracting plan
Commercial subcontract planG
Major program
In vivo study of generic drug products in human subjects
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Mar 10, 2020Base obligation at award: $1,499,415
Latest action
Jun 21, 2024 — CloseoutModification P00005; obligation change -$1; administrative: no change in scope or value
Latest substantive action
Jun 1, 2022 — Change orderModification P00004; obligation change +$19,744
Actions by type
  • Base award1
  • Supplemental agreement (within scope)2
  • Change order1
  • Closeout1
  • Other administrative action1
6 actions recorded, Mar 10, 2020 to Jun 21, 2024; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$1
Latest action: change in base and all options
-$1

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-X-0600-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression